The pharmacologic management of cardiovascular concerns is an intricate, evolving science that can stump even the most experienced nurse practitioners. This first of our two-part Comprehensive Cardiovascular Pharmacology series breaks down this complex field with a detailed review of statins for hyperlipidemia and the pharmaceutical management of coronary heart disease. Therapy with agents that inhibit thrombin in the treatment of venous thromboembolism is also discussed in depth.
Among the agents detailed in this presentation are thrombolytic, antiplatelet, hemostatic, and antiarrhythmic agents. The latest guidelines from the American College of Cardiology, the American Heart Association, and the National Lipid Association are provided to equip you with the most efficient, high-quality pharmacologic therapies for treating patients with cardiovascular disorders.